Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Public Health England (PHE) is seeking to commission an external partner with an existing system and / or capability to deliver an opioid and new psychoactive substances (NPS) clinical harms surveillance programme. The programme will:
⢠rapidly detect any incident involving synthetic opioids in the heroin or cocaine markets;
⢠monitor the emergence of a synthetic opioid market as seen in North America;
⢠identify health harms associated with toxicity from emerging/new NPS, such as synthetic cannabinoids.
To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal.
No supplier information available.